title: Edoxaban tosylate monohydrate, secukinumab, and suvorexant.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Jeena
authors.initials: J
authors.lastname: Jacob
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001381:Azepines / Q000008:administration & dosage / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000068776:Sleep Aids, Pharmaceutical / Q000008:administration & dosage / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001381:Azepines; D065427:Factor Xa Inhibitors; D011725:Pyridines; D000068776:Sleep Aids, Pharmaceutical; D013844:Thiazoles; D014230:Triazoles; C551624:suvorexant; C555450:secukinumab; C552171:edoxaban